Results from the extension of the RELAX study have shown that repeat onabotulinumtoxin A treatment in women with refractory idiopathic detrusor overactivity has consistent efficacy and duration of action. Up to three injections of treatment or placebo were offered to patients over a 5-year period and no statistically significant differences for symptom outcomes or time to symptom return were observed between injections.